ORKAMBI 125 mg/1
lumacaftor and ivacaftor · TABLET, FILM COATED · Vertex Pharmaceuticals Incorporated
ORKAMBI is a tablet, film coated containing lumacaftor and ivacaftor at 125 mg/1, taken oral. Manufactured by Vertex Pharmaceuticals Incorporated.
Key Facts
- Brand Name
- ORKAMBI
- Generic Name
- lumacaftor and ivacaftor
- NDC Code (Product)
51167-809- Manufacturer
- Vertex Pharmaceuticals Incorporated
- Strength
- 125 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA206038
- Drug Class
- Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC]
- Marketing Start
- 07/02/2015
Recall History
No Recall HistoryFrequently Asked Questions
What is ORKAMBI used for?
ORKAMBI contains lumacaftor and ivacaftor. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is ORKAMBI a controlled substance?
ORKAMBI is not classified as a controlled substance by the DEA.
What is the generic name for ORKAMBI?
The generic name for ORKAMBI is lumacaftor and ivacaftor. There are no other listed brand versions of lumacaftor and ivacaftor.
What is the NDC code for ORKAMBI 125 mg/1?
The NDC (National Drug Code) for ORKAMBI 125 mg/1 is 51167-809, listed by Vertex Pharmaceuticals Incorporated.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)